SEC Form D filing
Nirrin Technologies, Inc.
Biotech · Series A · Regulation D 506(b) · MA · Filed June 15, 2026
Offering amount
$9.7M
Exemption
Reg D 506(b)
Issuer state
MA
Filing date
June 15, 2026
Signature date
June 15, 2026
CIK
0001889145
Summary
Auto-generatedbioprocess monitoring and analytics technology provider, $9.7M Series A in MA
Generated automatically by a language model from the public SEC filing; may contain errors. Verify against the source document on EDGAR. FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.
Source
FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.